These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 20119975)
1. Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms. Hsu HP; Shan YS; Jin YT; Lai MD; Lin PW J Surg Oncol; 2010 Apr; 101(5):356-62. PubMed ID: 20119975 [TBL] [Abstract][Full Text] [Related]
2. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Chetty R; Serra S; Asa SL Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809 [TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer. Park S; Kim SW; Lee BL; Jung EJ; Kim WH Hepatogastroenterology; 2006; 53(67):28-32. PubMed ID: 16506371 [TBL] [Abstract][Full Text] [Related]
4. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Yoshida R; Kimura N; Harada Y; Ohuchi N Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480 [TBL] [Abstract][Full Text] [Related]
6. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
7. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Guo C; Liu QG; Yang W; Zhang ZL; Yao YM Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495 [TBL] [Abstract][Full Text] [Related]
8. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC; Lee MS Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049 [TBL] [Abstract][Full Text] [Related]
9. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
10. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728 [TBL] [Abstract][Full Text] [Related]
13. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival]. Zhou YN; Li M Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049 [TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
17. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Ramesh S; Nash J; McCulloch PG Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738 [TBL] [Abstract][Full Text] [Related]
18. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma]. Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787 [TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors? Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]